Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
6.21
+0.07 (1.14%)
At close: Aug 13, 2025, 4:00 PM
6.21
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:42 AM EDT

DAWN Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Revenue
187.64131.16----
Upgrade
Cost of Revenue
11.225.28----
Upgrade
Gross Profit
176.42125.88----
Upgrade
Selling, General & Admin
117115.4575.5461.2929.164.68
Upgrade
Research & Development
171.15222.7130.5285.6243.589.1
Upgrade
Operating Expenses
288.15338.15206.06146.9172.7413.78
Upgrade
Operating Income
-111.74-212.27-206.06-146.91-72.74-13.78
Upgrade
Interest Expense
------0.03
Upgrade
Interest & Investment Income
21.1419.717.194.750-
Upgrade
Other Non Operating Income (Expenses)
1.2109.22-0.04-0.02-0.02-30.03
Upgrade
EBT Excluding Unusual Items
-89.4-83.35-188.92-142.18-72.75-43.84
Upgrade
Other Unusual Items
--5----
Upgrade
Pretax Income
-89.4-88.35-188.92-142.18-72.75-43.84
Upgrade
Income Tax Expense
5.597.14----
Upgrade
Earnings From Continuing Operations
-95-95.5-188.92-142.18-72.75-43.84
Upgrade
Minority Interest in Earnings
----2.113.34
Upgrade
Net Income
-95-95.5-188.92-142.18-70.65-40.51
Upgrade
Preferred Dividends & Other Adjustments
----99.99-
Upgrade
Net Income to Common
-95-95.5-188.92-142.18-170.64-40.51
Upgrade
Shares Outstanding (Basic)
101938065376
Upgrade
Shares Outstanding (Diluted)
101938065376
Upgrade
Shares Change (YoY)
17.09%16.87%21.85%77.13%568.42%-6.67%
Upgrade
EPS (Basic)
-0.94-1.02-2.37-2.17-4.62-7.33
Upgrade
EPS (Diluted)
-0.94-1.02-2.37-2.17-4.62-7.33
Upgrade
Free Cash Flow
-65.52-80.28-147.08-109.9-48.54-13.58
Upgrade
Free Cash Flow Per Share
-0.65-0.86-1.84-1.68-1.31-2.46
Upgrade
Gross Margin
94.02%95.97%----
Upgrade
Operating Margin
-59.55%-161.84%----
Upgrade
Profit Margin
-50.63%-72.81%----
Upgrade
Free Cash Flow Margin
-34.92%-61.21%----
Upgrade
EBITDA
-108.81-210.71-206.03-146.85-72.72-13.77
Upgrade
EBITDA Margin
-57.99%-160.65%----
Upgrade
D&A For EBITDA
2.931.560.040.060.020.02
Upgrade
EBIT
-111.74-212.27-206.06-146.91-72.74-13.78
Upgrade
EBIT Margin
-59.55%-161.84%----
Upgrade
Revenue as Reported
187.64131.16----
Upgrade
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q